Cita APA

Friedman, C., D'Souza, A., Roufai, D., Tinker, A., de Miguel, M., Gambardella, V., . . . Solit, D. (2024). Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.

Citación estilo Chicago

Friedman, CF, et al. Targeting HER2-mutant Metastatic Cervical Cancer With Neratinib: Final Results From the Phase 2 SUMMIT Basket Trial. 2024.

Cita MLA

Friedman, CF, et al. Targeting HER2-mutant Metastatic Cervical Cancer With Neratinib: Final Results From the Phase 2 SUMMIT Basket Trial. 2024.